Access cutting-edge neurotrophic keratitis treatment through this clinical trial at a research site in Minnetonka. Study-provided care at no cost to qualified participants.
Access neurotrophic keratitis specialists in Minnetonka at no cost
This study follows strict safety protocols and ethical guidelines
All study-related neurotrophic keratitis treatment provided free
The Sponsor is developing KB801, a replication-defective, non-integrating herpes simplex virus type 1 (HSV-1)-derived vector engineered to deliver functional full-length human nerve growth factor (NGF) to the corneas of people with Stage 2 or 3 neurotrophic keratitis (NK) via topical application. This is a Phase 1/2, multicenter, double-masked, placebo-controlled study to evaluate the safety, tolerability, and preliminary efficacy of KB801 in these subjects.
Sponsor: Krystal Biotech, Inc.
Check if you qualify for this neurotrophic keratitis clinical trial in Minnetonka, MN
If you're searching for neurotrophic keratitis treatment options in Minnetonka, MN, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Minnetonka research site is actively enrolling participants for this clinical trial. You'll receive care from experienced neurotrophic keratitis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.